Tuesday, 20 April 2021 12:23

Genomic Testing: The Future of Skin Care Detection

Written by   Julie Karen, MD

Skin cancer is the most commonly diagnosed cancer in the United States, affecting more people than all other cancers combined. More than five million nonmelanoma skin cancers are diagnosed annually in this country. Diagnosis and treatment rates have risen steadily and education on the importance of preventative care has increased, which is critical when considering that regular daily use of a broad-spectrum sunscreen reduces the risk of developing squamous cell carcinoma (the second most common form of skin cancer) by 40%

Want to read more?

Subscribe to continue reading this article, plus gain access to all DERMASCOPE has to offer.

SUBSCRIBE

Dr. Julie KarenJulie Karen, MD, is a board-certified dermatologist specializing in skin cancer, laser surgery, antiaging, and the treatment of leg veins. She received her medical degree from Cornell University, completed her residency training at NYU Medical Center, and her fellowship training at NYU and Memorial Sloan Kettering. Karen is a Castle Connolly Top Doctor, and in 2020 she was again named a New York Times “Super Doctor,” and chosen as one of New York Magazine's “Best Doctors.” Karen has published numerous textbook chapters and dermatology articles.  

Want to read more?

Subscribe to our "Pro Membership" to continue reading this article.

Login to post comments

October 2021

Medical Blogs

  • The Vivace Experience
    The Vivace Experience So, let’s start with the name. Vivace is pronounced vēˈväˌCHā and is taking the aesthetics…

Brands of the Month

  • Celluma by Biophotas, Inc
  • Alexandria Professional
  • DMK Skin Revision Center